Contraceptive compositions and methods employing 1-substituted imidazole derivatives

Claim 1

A method of contraception in a female mammal comprising administering intravaginally, to a subject clinically asymptomatic of vaginal microbial infection, prior to coitus, a spermatostatically effective amount of a 1-substituted imidazole of the formula ##STR5## wherein: Ar is a member selected from the group consisting of phenyl, mono-, di- and tri-halophenyl, loweralkylphenyl, nitrophenyl, cyanophenyl and trifluoromethyl phenyl, and R is a member selected from the group consisting of alkyl, having from 1 to 10 carbons, cycloalkyl, lower alkenyl, aryl-lower alkyl and aryl-loweralkenyl, said aryl being a member selected from the group consisting of phenyl, mono-, di- and trihalophenyl, loweralkylphenyl, loweralkyloxyphenyl, nitrophenyl and trifluoromethylphenyl; or a pharmaceutically acceptable acid addition salt thereof.

Claim 2

A method of contraception in a female mammal comprising administering intravaginally, to a subject clinically asymptomatic of vaginal microbial infection, prior to coitus, a spermatostatically effective amount of a 1-substituted imidazole of the formula ##STR5## wherein: Ar is a member selected from the group consisting of phenyl, mono-, di- and tri-halophenyl, loweralkylphenyl, nitrophenyl, cyanophenyl and trifluoromethyl phenyl, and R is a member selected from the group consisting of alkyl, having from 1 to 10 carbons, cycloalkyl, lower alkenyl, aryl-lower alkyl and aryl-loweralkenyl, said aryl being a member selected from the group consisting of phenyl, mono-, di- and trihalophenyl, loweralkylphenyl, loweralkyloxyphenyl, nitrophenyl and trifluoromethylphenyl; or a pharmaceutically acceptable acid addition salt thereof.

Claim 3

A method of contraception in a female mammal comprising administering intravaginally, to a subject clinically asymptomatic of vaginal microbiol infection, prior to coitus, a spermatostatically effective amount of a 1-substituted imidazole of the formula ##STR6## in which each of R 1 , R 2 , and R 3 , independent of the other, is hydrogen or lower alkyl, R 4 is hydrogen; optionally substituted alkyl, alkenyl, alkynyl, aryl, aralkyl, aralkenyl, aralkynyl, aliphatic acyl, aromatic acyl, --R 4' --O--R 4" , where R 4' and R 4" are saturated or unsaturated hydrocarbon groups, alkyl-, alkenyl- or alkynyl-sulfonyl or arysulfonyl, or a group of the formula: ##STR7## in which: Y is an oxygen (--O--) or sulphur (--S--); R 12 is an optionally substituted lower alkoxy, lower alkenyloxy, lower alkynyloxy, lower alkylmercapto, lower alkenylmercapto, lower alkynylmercapto, aryloxy, arylmercapto, amino, mono(lower alkyl-, lower alkenyl-, or lower alkynyl-) amino, di(lower alkyl-, lower alkenyl-, or lower alkynyl-)amino, monoarylamino, diarylamino; arylsulfonamido, or monoarylamino, diarylamino; arylsulfonamido, or --N(lower alkyl)--CO--NH--lower alkyl; R 5 is hydrogen, alkyl, alkenyl or alkynyl or an optionally substituted aryl radical; each of R 6 and R 7 , independent of the other, is hydrogen or optionally substituted alkyl, alkenyl, alkynyl or aryl radical; each of R 8 , R 9 and R 10 , independent of the other is hydrogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkoxy, lower alkylthio radical, or an electronegative group; X is an oxygen or sulphur atom or a --SO--, SO 2 --, --NH--, or >N--R 11 group, R 11 being hydrogen or lower alkyl, lower alkenyl or lower alkynyl; m is an integer from 1 to 6; and n is 0 or 1, and their salts.

Claim 4

A method of contraception in a female mammal comprising administering intravaginally, to a subject clinically asymptomatic of vaginal microbiol infection, prior to coitus, a spermatostatically effective amount of a 1-substituted imidazole of the formula ##STR6## in which each of R 1 , R 2 , and R 3 , independent of the other, is hydrogen or lower alkyl, R 4 is hydrogen; optionally substituted alkyl, alkenyl, alkynyl, aryl, aralkyl, aralkenyl, aralkynyl, aliphatic acyl, aromatic acyl, --R 4' --O--R 4" , where R 4' and R 4" are saturated or unsaturated hydrocarbon groups, alkyl-, alkenyl- or alkynyl-sulfonyl or arysulfonyl, or a group of the formula: ##STR7## in which: Y is an oxygen (--O--) or sulphur (--S--); R 12 is an optionally substituted lower alkoxy, lower alkenyloxy, lower alkynyloxy, lower alkylmercapto, lower alkenylmercapto, lower alkynylmercapto, aryloxy, arylmercapto, amino, mono(lower alkyl-, lower alkenyl-, or lower alkynyl-) amino, di(lower alkyl-, lower alkenyl-, or lower alkynyl-)amino, monoarylamino, diarylamino; arylsulfonamido, or monoarylamino, diarylamino; arylsulfonamido, or --N(lower alkyl)--CO--NH--lower alkyl; R 5 is hydrogen, alkyl, alkenyl or alkynyl or an optionally substituted aryl radical; each of R 6 and R 7 , independent of the other, is hydrogen or optionally substituted alkyl, alkenyl, alkynyl or aryl radical; each of R 8 , R 9 and R 10 , independent of the other is hydrogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkoxy, lower alkylthio radical, or an electronegative group; X is an oxygen or sulphur atom or a --SO--, SO 2 --, --NH--, or >N--R 11 group, R 11 being hydrogen or lower alkyl, lower alkenyl or lower alkynyl; m is an integer from 1 to 6; and n is 0 or 1, and their salts.